-- 拜耳（BAYN.F）達成協議，將以最高24.5億美元的價格收購美國生物製藥公司Perfuse Therapeutics。 Perfuse Therapeutics專注於眼科疾病的治療。 根據週三發布的消息，根據擬議的交易條款，這家德國生命科學集團將向Perfuse Therapeutics支付3億美元的首付款，並根據里程碑事件支付後續款項。 拜耳將獲得PER-001的全部權益。 PER-001是一種正在研究的小分子內皮素受體拮抗劑，用於治療眼科疾病。該藥物目前正處於中期臨床開發階段，預計將成為治療青光眼和糖尿病視網膜病變的療法。 拜耳製藥業務發展與許可負責人尤爾根·埃克哈特（Juergen Eckhardt）表示：「透過此次收購，我們將增強我們在眼科領域的專業知識和產品線，並進一步鞏固我們致力於為患者開發急需療法的承諾。」他強調了這款在研藥物的潛力。 Perfuse Therapeutics 執行長兼創辦人 Sevgi Gurkan 也表達了與 Eckhardt 類似的觀點，並指出該公司的願景與拜耳的願景高度一致。 “他們擁有足夠的規模和全球資源，能夠充分發揮 PER-001 的潛力，從而改變人類失明的命運。” 此次收購預計將在獲得必要的監管機構和 Perfuse 股東批准後生效。 截至週三中午，拜耳的股票在德國 Xetra 交易所上漲超過 2%。
Related Articles
Sectors
Sector Update: Consumer
Consumer stocks were mixed premarket Wednesday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) retreating 0.4% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) advancing 1.4%.Amazon (AMZN) shares were up more than 1% a day after The Information reported the company-backed Anthropic will pay Alphabet's (GOOG, GOOGL) Google Cloud about $200 billion over five years for computing capacity and processors.
$AMZN$XLP$XLY
Asia
Tianneng Power's Unit Sells 1 Billion Yuan Bonds
Tianneng Power's (HKG:0819) unit Tianneng Battery Group completed the issue of 1 billion yuan bonds to professional investors, according to a Hong Kong bourse filing Thursday.The bonds carry a fixed interest rate of 1.58% per annum and will fall due in three years.The battery manufacturer intends to use proceeds to repay bank borrowings and bonds payable.
$HKG:0819
Mining & Metals
Market Chatter: Triton Uranium Eyes 2026 U.S. Listing As Nuclear Fuel Demand Rise
Triton Uranium is considering a U.S. listing through a merger with a special purpose acquisition company in 2026, its president Scott Evans told Reuters, as the company seeks to tap rising demand for nuclear fuel and bolster domestic supply.The Canada-based company has begun development work at its Atlas Project in Uranium City, Saskatchewan, where it controls about 46,742 acres of mineral claims, the report said.Triton is preparing to launch a 10,000-meter drill programme across four priority targets, including the Dubyna Mine area, with drilling scheduled to commence in June, the report added.The Reuters report noted earlier this year, Denison Mines Corp (DML.TO), and NexGen Energy (NXE.TO) received approval from the Canadian Nuclear Safety Commission to begin construction of their Wheeler River and Rook I projects, respectively, in northern Saskatchewan -- the first approvals for new Canadian uranium mines since 2004.Meanwhile, The Wall Street Journal noted, efforts to build new mines focus on the Athabasca Basin in the far north of western Canada's Saskatchewan province, where uranium-giant Cameco hasoperated for years. Cameco runs the world's two largest uranium operations: McArthur River/Key Lake, in service since 1983, and Cigar Lake, which began commercial operations in 2015.(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$CCO.TO$DML.TO$NXE.TO